Berry Genomics Co.,Ltd
Symbool: 000710.SZ
SHZ
9.49
CNYMarktprijs vandaag
-7.7234
Koers/Winst Verhouding
0.0509
Koers/Winst Groei Verhouding
3.34B
MRK Kapitalisatie
- 0.00%
DIV Rendement
Berry Genomics Co.,Ltd (000710-SZ) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 1232.03 | 352 | 338.1 | 421.7 | ||||||||||||||||||||||||||||||
balance-sheet.row.short-term-investments | 34.5 | 13.9 | 4.5 | 3.8 | ||||||||||||||||||||||||||||||
balance-sheet.row.net-receivables | 3941.76 | 828.5 | 1111.8 | 1156.3 | ||||||||||||||||||||||||||||||
balance-sheet.row.inventory | 908.64 | 229.3 | 230.9 | 233.9 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-current-assets | 250.28 | 63.2 | 46 | 94.7 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-current-assets | 6332.71 | 1473 | 1726.9 | 1906.6 | ||||||||||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 3993.92 | 923.4 | 1100.8 | 1130.7 | ||||||||||||||||||||||||||||||
balance-sheet.row.goodwill | 53.73 | 13.4 | 13.4 | 13.4 | ||||||||||||||||||||||||||||||
balance-sheet.row.intangible-assets | 356.44 | 90.5 | 77.5 | 74 | ||||||||||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 410.18 | 104 | 90.9 | 87.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.long-term-investments | 258.94 | 34.6 | 133.8 | 275.3 | ||||||||||||||||||||||||||||||
balance-sheet.row.tax-assets | 511.73 | 151.3 | 102.2 | 63.9 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 175.88 | 54.9 | 46.3 | 55.8 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 5350.65 | 1268.2 | 1474 | 1613.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-assets | 11683.36 | 2741.2 | 3200.9 | 3519.7 | ||||||||||||||||||||||||||||||
balance-sheet.row.account-payables | 1150.41 | 292.5 | 278.9 | 339.9 | ||||||||||||||||||||||||||||||
balance-sheet.row.short-term-debt | 992.54 | 257.9 | 216.7 | 200 | ||||||||||||||||||||||||||||||
balance-sheet.row.tax-payables | 90.75 | 25.4 | 15.8 | 28.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 309.73 | 45.7 | 131.5 | 199.3 | ||||||||||||||||||||||||||||||
Deferred Revenue Non Current | 44.63 | 11 | 12.1 | 3.7 | ||||||||||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 94.08 | - | - | - | ||||||||||||||||||||||||||||||
balance-sheet.row.other-current-liab | 117.07 | 9.3 | 105.6 | 6.8 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 450.88 | 83.5 | 166.8 | 227.4 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 16.88 | 3.5 | 4.9 | 13.6 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-liab | 3445.78 | 846.6 | 871.5 | 996 | ||||||||||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
balance-sheet.row.common-stock | 1416.25 | 353.5 | 354.6 | 354.6 | ||||||||||||||||||||||||||||||
balance-sheet.row.retained-earnings | 1660.45 | 257 | 684.2 | 942 | ||||||||||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 3067.81 | 0 | 485.6 | 416.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 1969.57 | 1253.5 | 777 | 777 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 8114.09 | 1864 | 2301.4 | 2490.2 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 11683.36 | 2741.2 | 3200.9 | 3519.7 | ||||||||||||||||||||||||||||||
balance-sheet.row.minority-interest | 123.49 | 30.6 | 27.9 | 33.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-equity | 8237.58 | 1894.6 | 2329.3 | 2523.7 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 11683.36 | - | - | - | ||||||||||||||||||||||||||||||
Total Investments | 293.44 | 48.4 | 138.3 | 279.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-debt | 1304.71 | 303.6 | 348.2 | 399.3 | ||||||||||||||||||||||||||||||
balance-sheet.row.net-debt | 107.18 | -34.6 | 14.6 | -18.6 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -398.22 | -252.2 | -109.9 | 205.7 | |||||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 91.48 | 102.7 | 106.4 | 76.9 | |||||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -39.4 | -37 | 8.2 | |||||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 51.2 | 22.4 | 7 | |||||||||||||||||||||||||
cash-flows.row.change-in-working-capital | 72.85 | -145.2 | -77.4 | -160.8 | |||||||||||||||||||||||||
cash-flows.row.account-receivables | 83.22 | -24.6 | -134.9 | -295.2 | |||||||||||||||||||||||||
cash-flows.row.inventory | 0.89 | 6.9 | -57.5 | 20.3 | |||||||||||||||||||||||||
cash-flows.row.account-payables | 0 | -88 | 152 | 105.9 | |||||||||||||||||||||||||
cash-flows.row.other-working-capital | -11.26 | -39.4 | -37 | 8.2 | |||||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 343.71 | 304.2 | 189.5 | 24.4 | |||||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 109.81 | 0 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -60.91 | -73.3 | -336.7 | -112.5 | |||||||||||||||||||||||||
cash-flows.row.acquisitions-net | 0.09 | 1.7 | 0.4 | 190.4 | |||||||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -35.7 | -53.3 | |||||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 7.2 | 20.2 | 24.5 | 54.4 | |||||||||||||||||||||||||
cash-flows.row.other-investing-activites | 1.16 | 2 | 0 | 0 | |||||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -59.66 | -49.4 | -347.5 | 79 | |||||||||||||||||||||||||
cash-flows.row.debt-repayment | -251.21 | -339.3 | -199 | -239.3 | |||||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 56.3 | -150.1 | |||||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -56.3 | -150.1 | |||||||||||||||||||||||||
cash-flows.row.dividends-paid | -14.77 | -17.6 | -20.3 | -29.2 | |||||||||||||||||||||||||
cash-flows.row.other-financing-activites | 131.46 | 275.6 | 264.2 | 553.2 | |||||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -100.5 | -81.3 | 44.8 | -15.6 | |||||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 2.53 | 11.2 | -2.7 | -6.7 | |||||||||||||||||||||||||
cash-flows.row.net-change-in-cash | -11.61 | -98.3 | -211.3 | 218 | |||||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 1158.27 | 318.3 | 416.6 | 627.9 | |||||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 1169.88 | 416.6 | 627.9 | 409.9 | |||||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 109.81 | 21.2 | 94 | 161.3 | |||||||||||||||||||||||||
cash-flows.row.capital-expenditure | -60.91 | -73.3 | -336.7 | -112.5 | |||||||||||||||||||||||||
cash-flows.row.free-cash-flow | 48.9 | -52.1 | -242.7 | 48.8 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1148.74 | 1151.4 | 1368 | 1422.2 | ||||||||||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 614.52 | 636.2 | 783.6 | 786 | ||||||||||||||||||||||||||||||
income-statement-row.row.gross-profit | 534.22 | 515.2 | 584.4 | 636.2 | ||||||||||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
income-statement-row.row.research-development | 110.03 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 26.94 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 279.09 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.other-expenses | -3.03 | -2.7 | 173.7 | 134.5 | ||||||||||||||||||||||||||||||
income-statement-row.row.operating-expenses | 544.91 | 545.2 | 607.6 | 620.1 | ||||||||||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 1159.43 | 1181.4 | 1391.3 | 1406 | ||||||||||||||||||||||||||||||
income-statement-row.row.interest-income | 4.54 | 2.6 | 2.4 | 5.1 | ||||||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 10.86 | 16.4 | 17.6 | 20.3 | ||||||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 279.09 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -9.9 | -2.7 | -260 | -81.6 | ||||||||||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -3.03 | -2.7 | 173.7 | 134.5 | ||||||||||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | -9.9 | -2.7 | -260 | -81.6 | ||||||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 10.86 | 16.4 | 17.6 | 20.3 | ||||||||||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 375.15 | 113.9 | -39 | 106.4 | ||||||||||||||||||||||||||||||
income-statement-row.row.ebitda-caps | -37.06 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.operating-income | -412.21 | -450.7 | -23.2 | -38.8 | ||||||||||||||||||||||||||||||
income-statement-row.row.income-before-tax | -422.11 | -453.4 | -283.3 | -120.4 | ||||||||||||||||||||||||||||||
income-statement-row.row.income-tax-expense | -26.37 | -28.2 | -31 | -10.5 | ||||||||||||||||||||||||||||||
income-statement-row.row.net-income | -398.22 | -427.2 | -252.2 | -109.9 |
Vaak gestelde vragen
Wat is Berry Genomics Co.,Ltd (000710.SZ) totale activa?
Berry Genomics Co.,Ltd (000710.SZ) totale activa is 2741165147.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is 563342266.000.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.465.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is -0.347.
Wat is de totale omzet van de onderneming?
De totale opbrengst is -0.359.
Wat is Berry Genomics Co.,Ltd (000710.SZ) nettowinst (netto-inkomen)?
De nettowinst is -427196505.920.
Wat is de totale schuld van het bedrijf?
De totale schuld is 303579022.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 545150751.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 246677815.000.